Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gynecologic Cancer × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 73 Nasopharyngeal Carcinoma 51 Uterine Cervical Neoplasms 37 Lung Neoplasms 35 Head and Neck Neoplasms 24 Esophageal Squamous Cell Carcinoma 24 Esophageal Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 18 Stomach Neoplasms 14 Small Cell Lung Carcinoma 14 Breast Neoplasms 14 Recurrence 11 Ovarian Neoplasms 10 Neoplasm Metastasis 9 Carcinoma, Squamous Cell 9 Nasopharyngeal Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 8 Central Nervous System Neoplasms 7 Pancreatic Neoplasms 6 Neuroblastoma 6 Lymphoma 6 Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Follicular 5 Hypopharyngeal Neoplasms 5 Biliary Tract Neoplasms 5 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 4 Oropharyngeal Neoplasms 4

Interventions

genexol-PM 1 Therapeutics 1 Radiotherapy, Intensity-Modulated 1 Preoperative Exercise 1 Population Groups 1 FloSeal Matrix 1 Exercise 1 Enhanced Recovery After Surgery 1 Drug Therapy 1 Counseling 1 Cisplatin 1 AGuIX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡